MAYBE CHARGING CONSUMERS THE LOW PRICE of $599 for a whole human genome sequence is not a winning financial strategy. That’s one possible reason why closely-watched Veritas Genetics of Cambridge, Mass., will stop operations in the United States. It was in July that Veritas announced it was cutting its already-low price to sequence a genome …
Veritas Genetics to Close Its Testing Operations in U.S. Read More »